Ann Hynes
Stock Analyst at Mizuho
(4.14)
# 459
Out of 5,134 analysts
281
Total ratings
61.9%
Success rate
9.47%
Average return
Main Sectors:
Stocks Rated by Ann Hynes
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| DGX Quest Diagnostics | Maintains: Outperform | $210 → $235 | $204.39 | +14.98% | 17 | Feb 12, 2026 | |
| UNH UnitedHealth Group | Maintains: Outperform | $430 → $350 | $288.20 | +21.44% | 22 | Feb 5, 2026 | |
| SGRY Surgery Partners | Maintains: Outperform | $22 → $19 | $15.99 | +18.82% | 4 | Dec 18, 2025 | |
| HCA HCA Healthcare | Maintains: Outperform | $505 → $520 | $535.02 | -2.81% | 23 | Dec 18, 2025 | |
| FTRE Fortrea Holdings | Maintains: Neutral | $11 → $13 | $10.44 | +24.52% | 6 | Dec 18, 2025 | |
| CRL Charles River Laboratories International | Maintains: Neutral | $174 → $200 | $158.00 | +26.58% | 4 | Dec 18, 2025 | |
| BTSG BrightSpring Health Services | Maintains: Outperform | $38 → $42 | $41.15 | +2.07% | 3 | Dec 18, 2025 | |
| ARDT Ardent Health | Maintains: Outperform | $20 → $12 | $9.76 | +22.95% | 4 | Dec 18, 2025 | |
| ACHC Acadia Healthcare Company | Maintains: Neutral | $22 → $17 | $16.93 | +0.41% | 13 | Dec 18, 2025 | |
| CVS CVS Health | Maintains: Outperform | $88 → $95 | $77.75 | +22.19% | 12 | Dec 10, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $420 → $400 | $346.24 | +15.53% | 6 | Nov 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $575 → $655 | $446.17 | +46.81% | 5 | Oct 24, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $194 → $225 | $231.75 | -2.91% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $285 → $320 | $278.76 | +14.79% | 16 | Oct 17, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $300 → $345 | $187.12 | +84.37% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $28 → $40 | $43.07 | -7.13% | 9 | Oct 9, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $190 → $225 | $171.06 | +31.53% | 13 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $173 → $225 | $96.50 | +133.16% | 16 | Jul 25, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Outperform | $400 → $330 | $142.61 | +131.40% | 9 | Jul 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $13 → $15 | $21.97 | -31.73% | 11 | Nov 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $110 → $120 | $224.99 | -46.66% | 8 | Nov 4, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Outperform | $28 | $23.73 | +17.99% | 1 | Aug 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $93 → $95 | $109.08 | -12.91% | 8 | Apr 25, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $370 → $385 | $290.12 | +32.70% | 10 | Mar 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $175 → $200 | $235.29 | -15.00% | 15 | Mar 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $242 → $268 | $1.76 | +15,127.27% | 1 | Feb 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $450 → $505 | $946.97 | -46.67% | 19 | Feb 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Neutral | $57 | $0.89 | +6,304.49% | 1 | Sep 21, 2017 |
Quest Diagnostics
Feb 12, 2026
Maintains: Outperform
Price Target: $210 → $235
Current: $204.39
Upside: +14.98%
UnitedHealth Group
Feb 5, 2026
Maintains: Outperform
Price Target: $430 → $350
Current: $288.20
Upside: +21.44%
Surgery Partners
Dec 18, 2025
Maintains: Outperform
Price Target: $22 → $19
Current: $15.99
Upside: +18.82%
HCA Healthcare
Dec 18, 2025
Maintains: Outperform
Price Target: $505 → $520
Current: $535.02
Upside: -2.81%
Fortrea Holdings
Dec 18, 2025
Maintains: Neutral
Price Target: $11 → $13
Current: $10.44
Upside: +24.52%
Charles River Laboratories International
Dec 18, 2025
Maintains: Neutral
Price Target: $174 → $200
Current: $158.00
Upside: +26.58%
BrightSpring Health Services
Dec 18, 2025
Maintains: Outperform
Price Target: $38 → $42
Current: $41.15
Upside: +2.07%
Ardent Health
Dec 18, 2025
Maintains: Outperform
Price Target: $20 → $12
Current: $9.76
Upside: +22.95%
Acadia Healthcare Company
Dec 18, 2025
Maintains: Neutral
Price Target: $22 → $17
Current: $16.93
Upside: +0.41%
CVS Health
Dec 10, 2025
Maintains: Outperform
Price Target: $88 → $95
Current: $77.75
Upside: +22.19%
Nov 4, 2025
Maintains: Outperform
Price Target: $420 → $400
Current: $346.24
Upside: +15.53%
Oct 24, 2025
Maintains: Outperform
Price Target: $575 → $655
Current: $446.17
Upside: +46.81%
Oct 17, 2025
Maintains: Outperform
Price Target: $194 → $225
Current: $231.75
Upside: -2.91%
Oct 17, 2025
Maintains: Outperform
Price Target: $285 → $320
Current: $278.76
Upside: +14.79%
Oct 9, 2025
Maintains: Outperform
Price Target: $300 → $345
Current: $187.12
Upside: +84.37%
Oct 9, 2025
Maintains: Neutral
Price Target: $28 → $40
Current: $43.07
Upside: -7.13%
Jul 25, 2025
Maintains: Outperform
Price Target: $190 → $225
Current: $171.06
Upside: +31.53%
Jul 25, 2025
Maintains: Outperform
Price Target: $173 → $225
Current: $96.50
Upside: +133.16%
Jul 11, 2025
Maintains: Outperform
Price Target: $400 → $330
Current: $142.61
Upside: +131.40%
Nov 19, 2024
Maintains: Neutral
Price Target: $13 → $15
Current: $21.97
Upside: -31.73%
Nov 4, 2024
Maintains: Neutral
Price Target: $110 → $120
Current: $224.99
Upside: -46.66%
Aug 19, 2024
Initiates: Outperform
Price Target: $28
Current: $23.73
Upside: +17.99%
Apr 25, 2024
Maintains: Buy
Price Target: $93 → $95
Current: $109.08
Upside: -12.91%
Mar 8, 2024
Maintains: Buy
Price Target: $370 → $385
Current: $290.12
Upside: +32.70%
Mar 6, 2024
Maintains: Buy
Price Target: $175 → $200
Current: $235.29
Upside: -15.00%
Feb 23, 2024
Maintains: Buy
Price Target: $242 → $268
Current: $1.76
Upside: +15,127.27%
Feb 9, 2024
Maintains: Neutral
Price Target: $450 → $505
Current: $946.97
Upside: -46.67%
Sep 21, 2017
Initiates: Neutral
Price Target: $57
Current: $0.89
Upside: +6,304.49%